Yocca Frank has filed 60 insider transactions across 1 company since January 2023.
Most recent transaction: a option exercise of 33 shares of BioXcel Therapeutics, Inc. ($BTAI) on March 14, 2026.
Activity breakdown: 0 open-market purchases and 8 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 14, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 33 | $0.00 | 97.0000 | 14,196,000 | 25.38% | 0.00% |
| March 15, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 35 | $0.00 | 247.0000 | 14,196,000 | 12.41% | 0.00% |
| March 14, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 33 | $0.00 | 6,485.0000 | 14,196,000 | 0.51% | 0.00% |
| March 15, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 35 | $0.00 | 6,520.0000 | 14,196,000 | 0.54% | 0.00% |
| Jan. 1, 2026 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | A | Restricted Stock Units | 70000 | $0.00 | 70,282.0000 | 14,196,000 | 9999.99% | 0.49% |
| Dec. 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 33 | $0.00 | 6,417.0000 | 14,196,000 | 0.52% | 0.00% |
| Dec. 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 35 | $0.00 | 6,452.0000 | 14,196,000 | 0.55% | 0.00% |
| Dec. 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 33 | $0.00 | 130.0000 | 14,196,000 | 20.25% | 0.00% |
| Dec. 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 35 | $0.00 | 282.0000 | 14,196,000 | 11.04% | 0.00% |
| Sept. 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 33 | $0.00 | 6,349.0000 | 7,843,000 | 0.52% | 0.00% |
| Sept. 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 35 | $0.00 | 317.0000 | 7,843,000 | 9.94% | 0.00% |
| Sept. 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 33 | $0.00 | 163.0000 | 7,843,000 | 16.84% | 0.00% |
| Sept. 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 35 | $0.00 | 6,384.0000 | 7,843,000 | 0.55% | 0.00% |
| Aug. 1, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | A | Restricted Stock Units | 9000 | $0.00 | 9,000.0000 | 7,843,000 | 9999.99% | 0.11% |
| July 22, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | A | Common Stock | 4375 | $0.00 | 6,316.0000 | 7,843,000 | 225.40% | 0.06% |
| June 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 33 | $0.00 | 1,906.0000 | 4,834,000 | 1.76% | 0.00% |
| June 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 35 | $0.00 | 1,941.0000 | 4,834,000 | 1.84% | 0.00% |
| June 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 35 | $0.00 | 352.0000 | 4,834,000 | 9.04% | 0.00% |
| June 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 33 | $0.00 | 196.0000 | 4,834,000 | 14.41% | 0.00% |
| July 22, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | A | Stock Option (right to buy) | 1875 | $0.00 | 1,875.0000 | 2,516,000 | 9999.99% | 0.07% |
| March 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 34 | $0.00 | 387.0000 | 2,535,000 | 8.08% | 0.00% |
| March 15, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 34 | $0.00 | 1,873.0000 | 2,535,000 | 1.85% | 0.00% |
| March 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 31 | $0.00 | 1,839.0000 | 2,535,000 | 1.71% | 0.00% |
| March 14, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 31 | $0.00 | 229.0000 | 2,535,000 | 11.92% | 0.00% |
| Jan. 7, 2025 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | A | Stock Option (right to buy) | 270000 | $0.00 | 270,000.0000 | 2,535,000 | 9999.99% | 10.65% |
| Dec. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 521 | $0.00 | 28,799.0000 | 2,649,000 | 1.84% | 0.02% |
| Dec. 16, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | S | Common Stock | 205 | $0.36 | 29,156.0000 | 2,649,000 | 0.70% | 0.01% |
| Dec. 16, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | S | Common Stock | 225 | $0.35 | 28,931.0000 | 2,649,000 | 0.77% | 0.01% |
| Dec. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 521 | $0.00 | 2,606.0000 | 2,649,000 | 16.66% | 0.02% |
| Dec. 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 562 | $0.00 | 5,064.0000 | 2,649,000 | 9.99% | 0.02% |
| Dec. 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 562 | $0.00 | 29,361.0000 | 2,649,000 | 1.95% | 0.02% |
| Sept. 17, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | A | Common Stock | 21250 | $0.00 | 35,453.0000 | 2,516,000 | 149.62% | 0.84% |
| Oct. 3, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | S | Common Stock | 7175 | $0.55 | 28,278.0000 | 2,649,000 | 20.24% | 0.27% |
| Sept. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 521 | $0.00 | 3,127.0000 | 2,516,000 | 14.28% | 0.02% |
| Sept. 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 521 | $0.00 | 13,995.0000 | 2,516,000 | 3.87% | 0.02% |
| Sept. 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 563 | $0.00 | 14,558.0000 | 2,516,000 | 4.02% | 0.02% |
| Sept. 16, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | S | Common Stock | 355 | $0.69 | 14,203.0000 | 2,516,000 | 2.44% | 0.01% |
| Sept. 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 563 | $0.00 | 5,625.0000 | 2,516,000 | 9.10% | 0.02% |
| June 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 521 | $0.00 | 13,284.0000 | 1,929,000 | 4.08% | 0.03% |
| June 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 562 | $0.00 | 13,846.0000 | 1,929,000 | 4.23% | 0.03% |
| June 17, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | S | Common Stock | 372 | $1.28 | 13,474.0000 | 1,929,000 | 2.69% | 0.02% |
| June 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 521 | $0.00 | 3,648.0000 | 1,929,000 | 12.50% | 0.03% |
| June 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 562 | $0.00 | 6,188.0000 | 1,929,000 | 8.33% | 0.03% |
| March 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 2250 | $0.00 | 6,750.0000 | 1,821,000 | 25.00% | 0.12% |
| March 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 521 | $0.00 | 4,169.0000 | 1,821,000 | 11.11% | 0.03% |
| April 4, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | S | Common Stock | 1067 | $2.64 | 12,763.0000 | 1,929,000 | 7.72% | 0.06% |
| March 15, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 2250 | $0.00 | 13,830.0000 | 1,821,000 | 19.43% | 0.12% |
| March 14, 2024 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 521 | $0.00 | 11,580.0000 | 1,821,000 | 4.71% | 0.03% |
| Dec. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 521 | $0.00 | 11,059.0000 | 29,268,000 | 4.94% | 0.00% |
| Dec. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 521 | $0.00 | 4,690.0000 | 29,268,000 | 10.00% | 0.00% |
| Sept. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 521 | $0.00 | 5,211.0000 | 29,187,000 | 9.09% | 0.00% |
| Sept. 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 521 | $0.00 | 10,538.0000 | 29,187,000 | 5.20% | 0.00% |
| June 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 521 | $0.00 | 5,732.0000 | 28,616,000 | 8.33% | 0.00% |
| June 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 521 | $0.00 | 10,017.0000 | 28,616,000 | 5.49% | 0.00% |
| March 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Common Stock | 2084 | $0.00 | 10,481.0000 | 28,015,000 | 24.82% | 0.01% |
| March 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | A | Restricted Stock Units | 9000 | $0.00 | 9,000.0000 | 28,015,000 | 9999.99% | 0.03% |
| March 14, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 2084 | $0.00 | 6,253.0000 | 28,015,000 | 25.00% | 0.01% |
| March 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | S | Common Stock | 985 | $19.69 | 9,496.0000 | 28,015,000 | 9.40% | 0.00% |
| March 15, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 28,015,000 | 9999.99% | 0.11% |
| Jan. 20, 2023 | BioXcel Therapeutics, Inc. | $BTAI | Yocca Frank | Chief Scientific Officer | S | Common Stock | 50000 | $30.00 | 8,397.0000 | 28,015,000 | 85.62% | 0.18% |